Abstract Therapeutic hypothermia (TH) is now provided as standard care to infants with moderate-severe hypoxic ischemic encephalopathy (HIE). The role of TH in limiting neuronal injury is well recognized, but its effect on hepatic injury which occurs frequently in neonatal HIE is not known. Our objective was to characterize biomarkers of liver injury and function in the setting of neonatal HIE and to describe whether HIE severity and provision of TH influence these hepatic biomarkers. We performed a multicenter retrospective study and compared hepatic biomarkers obtained during the first postnatal week, according to the severity of HIE and whether treated with TH. Of a total of 361 infants with HIE, 223
(62%) received TH and 138 (38%) were managed at normal temperature. Most hepatic biomarkers and C-reactive protein (CRP) were significantly associated with the severity of HIE (p < 0.001). Infants treated with TH had lower peak alanine aminotransferase (ALT) concentrations (p = 0.025) and a delay in reaching peak CRP concentration (p < 0.001).
Conclusion: We observed a significant association between the clinical grade of HIE and biomarkers of liver metabolism and function. Therapeutic hypothermia was associated with delayed CRP responses and with lower ALT concentrations and so may have the potential to modulate hepatic injury.
What is Known:
• Ischemic hepatic injury occurs frequently as a part of multiorgan dysfunction in infants with hypoxic ischemic encephalopathy (HIE).
• The neuroprotective role of therapeutic hypothermia in management of infants with HIE is well recognized, but the potential hepato-protective effects of hypothermia are unclear. What is New/What this study adds:
• Therapeutic hypothermia was associated with lower alanine aminotransferase and albumin concentrations and a delayed C-reactive protein (CRP) response and so may have the potential to modulate hepatic injury.
• An elevated CRP concentration during the first postnatal week may be regarded as an expected finding in moderate and severe HIE and, in the overwhelming majority of cases, occurs secondary to hepatic hypoxia-ischemia in the absence of blood culture-positive sepsis.
Introduction
Hypoxic ischemic hepatic injury occurs frequently as a part of multiorgan involvement in neonatal hypoxic ischemic encephalopathy (HIE) [3, 15, 24] . The pattern of hepatic injury is consistent with the hepatic ischemic insult seen in adults and children following cardiac arrest, namely, there is elevation of liver enzymes in the first few days after the insult and normalization within a few weeks [11, 13, 20] . Although a few small studies have examined hepatic enzyme changes in the setting of HIE [5, 6, 17, 20, 21, 27] , the effects of perinatal asphyxia on hepatic function and recovery are not well characterized, and the value of routine measurement of liver enzymes in infants admitted with suspected HIE is uncertain. Moderate whole body hypothermia is now provided as standard care to infants with moderate-severe HIE. The benefits of hypothermia in limiting neuronal injury and improving neurodevelopmental outcomes have been well documented [1, 2, 14, 26] . While some of the large randomized controlled trials of therapeutic hypothermia included study of liver enzyme elevation as secondary outcomes or reported them as adverse events [14, 26] , so far no studies have set out primarily to examine the potential influence of therapeutic hypothermia on hepatic biomarkers in infants with HIE.
C-reactive protein (CRP) is an acute phase reactant produced in the liver and is commonly measured in sick neonates in intensive care as a surrogate marker of infection [16, 30] . CRP concentrations may also be influenced by perinatal asphyxia in the presence of multiorgan involvement and in the absence of systemic infection. To date, only a few reports describe the relationship between perinatal hypoxia-ischemia, therapeutic hypothermia, and CRP responses [4, 19, 22, 23, 25] .
Our aims in this study were to (i) characterize hepatic injury in the setting of HIE by analyzing the hepatic biochemical markers and CRP concentrations in term and near-term infants during the first postnatal week, and (ii) describe any changes in markers of hepatic function and injury associated with severity of HIE and with provision of therapeutic hypothermia.
Methods
This was a retrospective review of clinical records conducted in four tertiary-level neonatal intensive care units (NICUs) in the UK. Infants eligible for inclusion were those born at ≥36 weeks gestational age in the 5-year period 1st July 2006 to 30th June 2011, and admitted to a participating NICU with a recorded diagnosis at death/discharge of HIE of any clinical severity (grades 1-3 Sarnat-Sarnat). We excluded infants who had a major congenital anomaly or a primary diagnosis of an inborn error of metabolism. Participating centers introduced routine whole-body therapeutic hypothermia for treating HIE at different times within this epoch.
Using a dedicated study proforma, we collected the results of all daily blood tests done in eligible infants from admission until completion of 7 postnatal days, or until death if it occurred earlier. We examined the following potential biomarkers of hepatic metabolism: alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transpeptidase (GGT), total and conjugated bilirubin, prothrombin time (PT), partial thromboplastin time (PTT), and C-reactive protein (CRP). For each biomarker, we recorded the peak plasma concentration each day during the first week, the postnatal day of occurrence of its peak concentration, and the proportion of infants having at least one abnormally elevated value within the first week. We also recorded the nadir plasma albumin concentration, postnatal day of occurrence, and the proportion of infants with an abnormally low albumin level. The following values were considered abnormal and therefore thresholds marking potential liver dysfunction: CRP ≥10 mg/L [4] , ALT >50 U/L, AST >140 U/L, GGT >263 U/L, PT >14.4 s, PTT >51.2 s, and albumin <26 g/L [10] . All blood tests had been performed according to routine local clinical practices and at the discretion of the attendant clinicians. We collected baseline data including clinical HIE grade as stated on the discharge summary, timing and duration of any therapeutic hypothermia given, and details of blood culture results and any associated maternal pyrexia or histopathologically confirmed chorioamnionitis.
Differences in baseline characteristics of infants with different grades of HIE and between hypothermia and control groups were analyzed using the Kruskal-Wallis test, and Mann-Whitney test for non-parametric variables. Chi-squared and Fisher's exact tests were used, as appropriate, to analyze proportions. The association between the potential markers of hepatic dysfunction and severity of HIE was analyzed using the Kruskal-Wallis test. Any biomarkers measured in less than a third of the cohort overall were excluded from analysis.
The effect of hypothermia on the hepatic biomarkers was analyzed by comparing the peak concentrations of the hepatic enzymes and CRP between the cohort of neonates who received whole body therapeutic hypothermia (Bhypothermia group^) and the cohort who did not receive therapeutic hypothermia (Bnormothermia group^) using the Mann-Whitney test. As both hypothermia and normothermia groups included infants with varying severity of HIE, infants were also stratified based on grade of HIE and an additional analysis was done limited to those with moderate or severe HIE (grades 2 and 3 combined) after excluding mild (grade 1) cases. Furthermore, a multiple regression analysis using logarithmically transformed values for each hepatic biomarker was performed for the complete cohort to assess the association between extreme values of each analyte and the reception of therapeutic hypothermia after adjusting for grade of HIE and birth weight.
This study had prior approval from a UK National Research Ethics Service ethics committee (REC reference: 11/EE/0349).
Results
Three hundred sixty-one eligible neonates were admitted to the four centers during the study period: 101 (28%) had grade 1 HIE, 165 (46%) had grade 2 HIE, and 95 (26%) had grade 3 HIE. In total, 138 (38%) infants were managed at normal temperature (n = 69 HIE grade 1; n = 47 HIE grade 2; n = 22 HIE grade 3), and 223 (62%) received therapeutic hypothermia (n = 32 HIE grade 1; n = 118 HIE grade 2; and n = 73 HIE grade 3).
For each hepatic biomarker, the percentage (and number) of eligible infants having at least one recorded sample available in the first 7 days, along with median (range) number of samples, were as follows: ALT 96% (347/361), 3 (1-7); albumin 99% (356/361), 5 (1-7); CRP 99% (357/361), 5 (1-7); total bilirubin 81% (294/361), 5 (1-7); PT 77% (278/361), 1(1-7); PTT 64% (238/361), 1 (1-7); and AST 40% (145/ 361), 3 (1-6). Conjugated bilirubin and GGT were excluded from analysis because values for these were available in only 22% (80/361) and 20% (71/361) cases, respectively.
Baseline patient characteristics are shown in Table 1 , with comparison according to HIE grade and reception of hypothermia. The overall rate of culture-positive infection among the whole cohort was 2.8% (10/361) with no difference between the HIE grades or between hypothermia and normothermia groups. The results of histopathological placental examination were available for only 57 (15.7%) of the 361 infants, of which 18 (32%) showed evidence of chorioamnionitis and/ or funisitis [7] .
Effects of HIE severity and therapeutic hypothermia on hepatic biomarkers Table 2 presents the peak values of hepatic biomarkers measured in the first postnatal week, and the proportions of infants having a raised value for each biomarker according to HIE grade. The peak values of the hepatic biomarkers of injury including ALT and AST increased with severity of HIE grade (p < 0.001). Similarly, higher proportions of infants were affected with abnormally elevated ALT and AST concentrations with increasing HIE severity.
The biomarkers reflecting hepatic synthetic function, namely, albumin and PT, differed according to HIE grade: infants with more severe HIE had significantly lower nadir albumin concentrations and lower peak total bilirubin concentrations (both p < 0.0001), and a longer PT (p < 0.0001) ( Table 2) . Proportions of infants affected by an abnormally low plasma albumin value and a prolonged PT were also higher with increasing HIE severity ( Table 2 , Fig. 1 ). Table 3 shows the results of univariate analysis according to reception of hypothermia treatment. Comparison between the hypothermia-treated and normothermia groups showed lower nadir albumin concentrations and longer PT and PTT times with hypothermia, but no differences for the other hepatic biomarkers. Sub-grouping according to grade of HIE showed significant differences associated with hypothermia reception for only a lower nadir albumin in grade 1 HIE and a longer PTT in grade 2 HIE (Online Resource Table S1 ). Univariate analysis limited to the sub-group of infants with moderate or severe encephalopathy (grades 2 and 3 HIE combined) showed that only a longer PTT was associated with hypothermia therapy (Online Resource Table S1 ).
After adjusting for grade of HIE and birth weight in a multivariate regression analysis, only ALT and albumin were significantly affected by therapeutic hypothermia: infants in the hypothermia group had lower peak ALT (p = 0.025) and a lower nadir plasma albumin (p = 0.049) compared with the normothermia infants, and there were no differences between the hypothermia and normothermia treated infants for any of the other biomarkers including AST, bilirubin, PT, and PTT (Table 4) .
Effect of HIE severity and therapeutic hypothermia on peak CRP concentration A raised CRP was present in 206/357 (57.7%) neonates during the first postnatal week (Table 2) , with the peak occurring on postnatal day 4 overall. Proportions with a raised CRP increased with severity of HIE grade (p < 0.0001). Considering only neonates with moderate or severe HIE (grades 2 and 3), it is noteworthy that the majority had a raised CRP within the first postnatal week (166/258; 64.3%), while only a small minority (8/246; 3.3%) had culture-positive sepsis (Table 1) . CRP concentrations also peaked later in grades 2 and 3 HIE compared to grade 1 HIE (p = 0.0001) ( Table 2 ).
Univariate analysis showed that compared with HIE infants who did not receive hypothermia, the hypothermia-treated group had a higher peak CRP (15.4 versus 9.3 mg/L, p = 0.01) and a higher proportion of infants with a raised CRP (62.6 versus 49.6%) ( Table 3) . After adjusting for HIE grade and birth weight, the multivariate regression showed no difference in peak CRP concentration between hypothermia and normothermia groups (p = 0.5); however, the time to peak was delayed in the hypothermia-treated group (p < 0.001) ( Table 4) . Figure 2 depicts changes in daily mean concentrations of peak CRP values over the first 7 days of life in normothermia and hypothermia groups with a delayed peak noted in infants who received hypothermia.
Discussion
With this study, we sought to determine the effect of hypoxic injury on surrogate biomarkers of hepatocellular integrity (ALT, AST) and hepatic synthetic function (albumin, PT) in neonates with HIE [12] . We believe this is the largest study to characterize markers of hepatic injury and function in the setting of neonatal HIE [5, 6, 17, 20, 21, 27] and, to our knowledge, the first to present baseline reference values for a range of hepatic biomarkers in the era of routine therapeutic hypothermia. Both hypoxic ischemic neuronal and hepatic injury can occur secondary to perinatal asphyxia. We observed significant correlations between severity of HIE and values of several hepatic biochemical markers within the first 7 days after birth. More severe HIE was associated with greater elevation of hepatic enzymes (ALT, AST) and with abnormalities of markers of hepatic synthetic function (albumin, PT).
Effect of severity of HIE on hepatic biochemical markers
Several smaller studies have reported an increase in some hepatic enzymes in infants with perinatal asphyxia and neonatal encephalopathy, including for AST and ALT [5, 6, 17, 20, 24, 27] . Some have examined the correlation of hepatic biomarkers with severity of encephalopathy [5, 6, 17, 20] . Of these, three reported significant correlation between hepatic enzymes and severity of neonatal encephalopathy [6, 17, 20] , while one study reported no correlation [5] . The inconsistency may be due to the relatively small numbers of infants studied, differing definitions of abnormal values of hepatic markers, and small cohorts making them relatively underpowered for assessing correlations with HIE severity.
Changes in hepatic biomarkers with therapeutic hypothermia
Hypothermia limits neuronal injury in neonates with HIE [8, 28] and improves neuro-developmental outcomes [1, 2, 14, 26]; however, effects of hypothermia on other organ systems are less well studied. Vejchapipat et al. performed an experimental study using a rat model and reported that moderate hypothermia (30-33°C) ameliorates liver energy failure compared to controls after intestinal ischemic reperfusion injury [29] . A meta-analysis of six randomized controlled trials which included 975 infants (316 of whom had hepatic dysfunction defined by using a higher threshold of AST >200 and/or ALT >100 U/L) showed no significant hepatoprotective effect of therapeutic hypothermia (relative risk 0.88 [95% CI 0.74 to 1.05]) [18] . However, the frequency and completeness of liver function testing in neonates in the included trials was unclear, and the use of a stricter definition of liver dysfunction may have decreased the sensitivity for detecting an effect. In our cohort, we observed inconsistent results for individual hepatic markers, with significantly lower peak ALT concentrations in the hypothermia group, but no difference for AST concentrations. This may possibly be due to the relatively lower number of babies with available AST samples. Nevertheless, ALT is considered to be a more specific marker for hepatic injury than AST which can be elevated due to other non-hepatic causes [12, 27] . The biomarkers of hepatic function again showed varying results with a marginally lower albumin in the hypothermia group (p = 0.049), but no difference in PT. The latter result is consistent with the meta-analysis of randomized controlled studies of therapeutic hypothermia which found no difference in coagulopathy between the hypothermia and control groups [18] .
Effect of severity of HIE and hypothermia on CRP responses
Several studies have examined CRP concentrations in the setting of HIE. [4, 19, 22, 23, 25, 30] . Shang et al. found a higher CRP concentration correlated with increasing clinical HIE severity in 74 infants [25] . Our study in a much larger cohort confirms that peak CRP concentrations and also proportions affected by a raised CRP both correlate strongly with HIE severity. Indeed, a raised CRP appears to be an expected finding during the first postnatal week in neonates admitted with moderate or severe HIE; in our cohort, this was nearly always in the absence of infection because the rate of culture-positive infection was only 2.8% overall. This discrepancy may have clinical implications because it may help influence a more Fig. 1 Hepatic biomarkers and grades of HIE: The biomarkers are reported in median with interquartile ranges. All infants with at least one measurement available were included judicious use of antibiotics in infants admitted with HIE, particularly in those with negative cultures, and perhaps a higher threshold for performing repeated full infection screens later in the first week in the presence of a raised CRP despite invariable initial antibiotic treatment. Despite the low rate of proven sepsis, we found a high rate of chorioamnionitis (32%) for those infants whose placentas had been submitted for examination, highlighting the importance of formal routine placental examination in infants admitted after perinatal asphyxia [7] .
Hypothermia is known to modulate leukocyte and immune responses with altered and delayed expression of inflammatory mediators and cytokines including IL-6 [4, 19, 23] . CRP is an acute phase reactant protein produced in the liver in response to the pro-inflammatory cytokine IL-6 [9] . Perrone [4, 23] . Okumus et al. recently showed that CRP responses were altered with therapeutic hypothermia with significantly higher levels of CRP, which peaked at day 4 of life compared to a normothermia group which showed no variation in CRP with time [22] . While we did not find any difference in peak CRP levels between our hypothermia-treated infants and those managed at normal temperature, we nevertheless also found a delay in peak CRP responses with therapeutic hypothermia, in line with these previous studies [4, 23] . Our study has a few limitations. This was a retrospective study and hence data were not available for all desired variables. Not all NICUs measured all hepatic biomarkers routinely and consistently; therefore, we needed to exclude the biomarkers GGT and conjugated bilirubin where a high proportion of biomarkers were unmeasured. Furthermore, we recognize that not all measured hepatic enzymes and biomarkers are wholly specific for the liver, for example, AST and PT can be elevated due to non-hepatic causes. Similarly, CRP is commonly elevated in infection and in other inflammatory conditions, although rates of culture-positive sepsis were very low in our cohort. Therapeutic hypothermia was introduced at different times in our participating centers during the study period and the normothermia group included infants with moderate and severe HIE, who may have qualified for therapeutic hypothermia before it became standard care. To address this limitation, we performed multiple regression analysis to adjust for effect of severity of HIE on hepatic biomarkers while assessing for influence of therapeutic hypothermia. Our analysis of biomarkers was confined to samples obtained in the first postnatal week, and more longitudinal variation in these biomarkers remains unknown. Strengths of our study are that it presents data on hepatic markers associated with HIE in the largest cohort to date, and that it provides preliminary reference ranges for a number of hepatic biomarkers in encephalopathic infants, most of whom received therapeutic hypothermia.
Conclusion
In our retrospective study of a large cohort of infants with HIE, we have observed a significant association between the clinical grade of HIE and several markers of liver metabolism and function. Therapeutic hypothermia was associated with delayed CRP responses and with lower ALT and albumin concentrations. More studies will be required to prove a definitive effect of hypothermia on limiting hepatic injury. However, as hypothermia is now standard treatment in moderate-severe HIE, future prospective randomized controlled studies will not be possible in human infants and the best inferences may therefore need to come from animal models. drafted the data collection form, and helped obtain the ethics approval; also collected the local data, co-wrote the first manuscript draft, led on manuscript re-drafting, provided intellectual input, finalized the revised manuscript version, and approved the final submitted manuscript version.
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